These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25174916)

  • 21. Subcutaneous adipose tissue metabolism at menopause: importance of body fatness and regional fat distribution.
    Mauriège P; Imbeault P; Prud'Homme D; Tremblay A; Nadeau A; Després JP
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2446-54. PubMed ID: 10902792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM
    Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen reduces 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats.
    Andersson T; Söderström I; Simonyté K; Olsson T
    Obesity (Silver Spring); 2010 Mar; 18(3):470-5. PubMed ID: 19763091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.
    Samaras K; Hayward CS; Sullivan D; Kelly RP; Campbell LV
    Diabetes Care; 1999 Sep; 22(9):1401-7. PubMed ID: 10480500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women.
    Paatela H; Wang F; Vihma V; Savolainen-Peltonen H; Mikkola TS; Turpeinen U; Hämäläinen E; Jauhiainen M; Tikkanen MJ
    Eur J Endocrinol; 2016 Feb; 174(2):167-75. PubMed ID: 26553725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progestins and androgens.
    Whitehead M
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):161S-167S. PubMed ID: 7958012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopause Is a Determinant of Breast Aromatase Expression and Its Associations With BMI, Inflammation, and Systemic Markers.
    Brown KA; Iyengar NM; Zhou XK; Gucalp A; Subbaramaiah K; Wang H; Giri DD; Morrow M; Falcone DJ; Wendel NK; Winston LA; Pollak M; Dierickx A; Hudis CA; Dannenberg AJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1692-1701. PubMed ID: 28323914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian hormones and obesity.
    Leeners B; Geary N; Tobler PN; Asarian L
    Hum Reprod Update; 2017 May; 23(3):300-321. PubMed ID: 28333235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
    Meilahn EN; Cauley JA; Tracy RP; Macy EO; Gutai JP; Kuller LH
    Am J Epidemiol; 1996 Jan; 143(2):159-66. PubMed ID: 8546117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular pharmacology of hormone replacement therapy.
    Rosano GM; Panina G
    Drugs Aging; 1999 Sep; 15(3):219-34. PubMed ID: 10503814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women.
    Ferrara CM; Lynch NA; Nicklas BJ; Ryan AS; Berman DM
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4166-70. PubMed ID: 12213866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
    Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
    Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal changes in abdominal fat distribution with menopause.
    Franklin RM; Ploutz-Snyder L; Kanaley JA
    Metabolism; 2009 Mar; 58(3):311-5. PubMed ID: 19217444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of estrogen replacement therapy on abdominal fat compartments as related to glucose and lipid metabolism in early postmenopausal women.
    Mattiasson I; Rendell M; Törnquist C; Jeppsson S; Hulthén UL
    Horm Metab Res; 2002 Oct; 34(10):583-8. PubMed ID: 12439787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute Female Hypogonadism Alters Adipose Tissue Fatty Acid Storage Factors and Chylomicronemia.
    Santosa S; Bonnes SL; Jensen MD
    J Clin Endocrinol Metab; 2016 May; 101(5):2089-98. PubMed ID: 27003301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of estrogens in the adipose tissue milieu.
    Bracht JR; Vieira-Potter VJ; De Souza Santos R; Öz OK; Palmer BF; Clegg DJ
    Ann N Y Acad Sci; 2020 Feb; 1461(1):127-143. PubMed ID: 31868931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.